Skip to Content
Merck
CN
  • Interactions of volatile anaesthetics with rocuronium bromide in perspective.

Interactions of volatile anaesthetics with rocuronium bromide in perspective.

European journal of anaesthesiology. Supplement (1994-01-01)
S Agoston
ABSTRACT

A review of several publications shows that there is general agreement that inhalational anaesthetic agents potentiate the neuromuscular effects of rocuronium in the same order as other similar agents, namely; enflurane and isoflurane > halothane > intravenous anaesthetics. However, such potentiation is not evident during induction and only becomes significant as anaesthesia becomes more prolonged. It is manifest as a prolongation in the duration of action of maintenance doses and a decrease in the recovery rate. During long-lasting procedures in which enflurane or isoflurane are used, smaller than usual maintenance doses or lower infusion rates should be employed.

MATERIALS
Product Number
Brand
Product Description

Rocuronium for peak identification, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Rocuronium bromide, ≥97% (perchloric acid titration)
Rocuronium bromide, European Pharmacopoeia (EP) Reference Standard